Clinical trial
Early Changes in Non-Invasive Hepatic and Metabolic Indices After Incretin-Based Therapy in Patients With Overweight or Obesity: Real-World Evidence From a Turkish Cohort
NCT07701005 is registered in ClinicalTrials.gov with Goztepe Prof Dr Suleyman Yalcın City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Changes in Non-Invasive Hepatic and Metabolic Indices After Incretin-Based Therapy in Patients With Overweight or Obesity: Real-World Evidence From a Turkish Cohort
- Lead sponsor
- Goztepe Prof Dr Suleyman Yalcın City Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- April 15, 2026
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insulin resistance, metabolic liver injury, obesity, overweight, steatosis of liver